Global Pharmaceutical Contract Packaging Market Size By Service Type (Primary Packaging, Secondary Packaging, Tertiary Packaging), By Packaging Type (Solid Dosage, Liquid Dosage, Parental Packaging), By Application (Prescription Drugs, Over-the-counter Drugs, Clinical Trials), By Geographic Scope And Forecast

Pharmaceutical Contract Packaging Market Size And Forecast

Pharmaceutical Contract Packaging Market size was valued to be USD 15.81 Billion in the year 2023 and it is expected to reach USD 34.39 Billion in 2031, at a CAGR of 10.20% over the forecast period of 2024 to 2031.

• Pharmaceutical contract packaging refers to the outsourcing of packaging services for pharmaceutical products and medications to specialized third-party companies.
• It involves activities such as primary packaging (bottles, blisters, pouches), secondary packaging (cartons, labels), and tertiary packaging (bundling, palletizing) of pharmaceutical products according to regulatory standards and client specifications.
• Pharmaceutical contract packaging is utilized by drug manufacturers and companies to enhance operational efficiency, reduce costs associated with in-house packaging operations, and gain access to specialized packaging technologies and expertise.
• It enables pharmaceutical companies to focus on core competencies such as drug development and manufacturing while leveraging the specialized capabilities of contract packaging organizations for packaging needs across various product types and therapeutic areas.

Pharmaceutical Contract Packaging Market Dynamics

The key market dynamics that are shaping the Pharmaceutical Contract Packaging Market include

Key Market Drivers

• Increasing Outsourcing TrendsThe demand for pharmaceutical contract packaging is being driven by the growing trend of outsourcing non-core activities among pharmaceutical companies. It allows them to focus on their core competencies, such as drug development and manufacturing, while leveraging the expertise and capabilities of specialized contract packaging organizations.
• Cost Optimization StrategiesPharmaceutical contract packaging is being adopted as a cost-effective solution for companies seeking to optimize their operational costs and reduce capital investments in packaging facilities and equipment. Contract packagers can offer economies of scale and efficient operations, leading to cost savings for pharmaceutical clients.
• Regulatory Compliance RequirementsStringent regulatory requirements governing the packaging of pharmaceutical products are driving the need for specialized contract packaging services. Contract packagers possess the necessary expertise, infrastructure, and quality control systems to ensure compliance with regulatory standards, such as those set by the FDA, EMA, and other governing bodies.
• Access to Advanced Packaging TechnologiesPharmaceutical companies are leveraging contract packaging services to gain access to advanced packaging technologies and specialized capabilities without incurring substantial capital investments. Contract packagers continually invest in state-of-the-art equipment and technologies, offering clients access to innovative packaging solutions.
• Flexibility and ScalabilityPharmaceutical contract packaging provides flexibility and scalability to accommodate varying production volumes and packaging requirements. Contract packagers can rapidly scale up or down their operations to meet fluctuating demand, enabling pharmaceutical companies to respond to market dynamics effectively.
• Globalization and Supply Chain OptimizationAs pharmaceutical companies expand their global reach, they are turning to contract packaging services to optimize their supply chain and distribution networks. Contract packagers with strategically located facilities can offer packaging solutions closer to target markets, reducing transportation costs and lead times.

Key Challenges

• Maintaining Strict Quality ControlStringent quality control measures are required in pharmaceutical contract packaging to ensure product integrity, safety, and compliance with regulatory standards. Deviations or lapses in quality control systems can lead to costly product recalls, regulatory penalties, and damage to a company’s reputation.
• Management of Validations and DocumentationExtensive documentation and validation processes are mandated in the pharmaceutical industry, posing challenges for contract packagers. Rigorous validation of equipment, processes, and systems is necessary to demonstrate compliance and maintain audit trails, adding to operational complexities and costs.
• Cold Chain ManagementFor temperature-sensitive pharmaceutical products, such as biologics and certain drug formulations, effective cold chain management during packaging and distribution is critical. Maintaining the required temperature ranges throughout the supply chain presents logistical challenges and requires specialized infrastructure and expertise.
• Serialization and Track-and-Trace ComplianceSerialization and track-and-trace regulations are being implemented globally to combat counterfeit drugs and ensure product traceability. Compliance with these regulations necessitates the integration of serialization systems and processes, increasing operational complexities and costs for contract packagers.
• Handling Potent and Hazardous MaterialsCertain pharmaceutical products, such as highly potent drugs or cytotoxic compounds, require specialized handling and containment measures during packaging to protect personnel and prevent cross-contamination. This necessitates specialized facilities, equipment, and training, adding complexity and cost to operations.
• Capacity Management and ScalabilityEffective capacity management and scalability are crucial for contract packagers to meet fluctuating demand from pharmaceutical clients. Maintaining operational flexibility while ensuring efficient resource utilization and minimizing idle capacity poses challenges in terms of forecasting, planning, and resource allocation.

Key Trends

• Adoption of Serialization and Track-and-Trace TechnologiesSerialization and track-and-trace technologies are being increasingly adopted in pharmaceutical contract packaging to comply with regulatory requirements and combat counterfeit products. These technologies enable the unique identification and traceability of individual drug packages throughout the supply chain.
• Expansion of Cold Chain Packaging ServicesA growing trend is being observed in the expansion of cold chain packaging services for temperature-sensitive pharmaceutical products, such as biologics and certain drug formulations. Contract packagers are investing in specialized infrastructure, including refrigerated storage and transportation solutions, to meet the increasing demand for these services.
• Integration of Automation and RoboticsAutomation and robotic technologies are being integrated into pharmaceutical contract packaging operations to enhance efficiency, accuracy, and productivity. Automated systems are being utilized for tasks such as picking, sorting, labeling, and palletizing, reducing the risk of human error and improving operational speed.
• Adoption of Advanced Packaging TechnologiesContract packagers are embracing advanced packaging technologies, such as specialized coatings, blister packaging, and child-resistant packaging, to meet the diverse needs of pharmaceutical clients. These technologies improve product stability, safety, and convenience for patients.
• Focus on Sustainability and Environmental ResponsibilityThere is an increasing focus on sustainability and environmental responsibility in the pharmaceutical contract packaging industry. Initiatives are being undertaken to reduce waste, optimize material usage, and explore eco-friendly packaging solutions to minimize the environmental impact of operations.
• Expansion of Global Footprint and NearshoringContract packagers are expanding their global footprint and exploring nearshoring opportunities to establish packaging facilities closer to pharmaceutical clients and end markets. This trend aims to optimize supply chains, reduce lead times, and enhance responsiveness to local market demands.

Pharmaceutical Contract Packaging Market Regional Analysis

Here is a more detailed regional analysis of the Pharmaceutical Contract Packaging Market

North America

• North America is considered the dominant region in the pharmaceutical contract packaging market, driven by the presence of a well-established pharmaceutical industry and a large number of contract packaging organizations.
• In the United States, the demand for contract packaging services is being fueled by the increasing outsourcing trends among pharmaceutical companies seeking to focus on core competencies and optimize operational costs.
• The stringent regulatory environment in North America is driving the need for specialized contract packaging services that ensure compliance with rigorous quality standards and regulatory requirements set by the FDA and other governing bodies.
• Access to advanced packaging technologies and automation solutions is a key factor contributing to the growth of the pharmaceutical contract packaging market in North America.
• The region’s well-developed transportation and logistics infrastructure, coupled with the presence of major pharmaceutical companies and contract packagers, has facilitated the efficient distribution of packaged pharmaceutical products.

Asia Pacific

• The Asia Pacific region is witnessing rapid growth in the pharmaceutical contract packaging market, driven by the expanding pharmaceutical industry, increasing outsourcing activities, and the presence of low-cost manufacturing hubs.
• Countries like India and China are emerging as attractive destinations for pharmaceutical contract packaging services, offering cost-effective solutions and access to skilled labor.
• The growing demand for generic drugs and the rise of biosimilars in the Asia Pacific region are fueling the need for specialized packaging capabilities, which contract packagers can provide.
• Investments in pharmaceutical manufacturing and packaging facilities by both domestic and international companies are contributing to the growth of the contract packaging market in the region.
• Initiatives by governments in various Asia Pacific countries to attract foreign direct investment and promote the pharmaceutical industry are supporting the expansion of contract packaging services.
• The growing adoption of serialization and track-and-trace technologies in the region, driven by regulatory requirements, is creating opportunities for contract packagers to offer specialized serialization services.

Pharmaceutical Contract Packaging Market Segmentation Analysis

The Pharmaceutical Contract Packaging Market is segmented based on Service Type, Packaging Type, Application, and Geography.

Pharmaceutical Contract Packaging Market, By Service Type

• Primary Packaging
• Secondary Packaging
• Tertiary Packaging
• Services with added value

Based on service type, the Pharmaceutical Contract Packaging Market is segmented into Primary Packaging and other segments. The Primary Packaging segment accounts for a significant market share, driven by the following factorsPrimary packaging refers to the immediate packaging material that comes into direct contact with the pharmaceutical product, such as bottles, blisters, vials, and ampoules. Primary packaging plays a crucial role in ensuring product integrity, stability, and protection from environmental factors, making it an essential component of the pharmaceutical supply chain.

Pharmaceutical Contract Packaging Market, By Packaging Type

• Solid Dosage
• Liquid Dosage
• Parenteral Packaging
• Biologics Packaging

Based on packaging type, the Pharmaceutical Contract Packaging Market is segmented into Solid Dosage and other segments. The Solid Dosage segment accounts for a significant market share, driven by the following factorsSolid dosage forms, such as tablets, capsules, and powders, represent a large portion of the pharmaceutical product portfolio, leading to a high demand for contract packaging services tailored to these formulations. Packaging requirements for solid dosage forms are being influenced by factors such as product stability, moisture protection, and child-resistant packaging needs, necessitating specialized packaging solutions and materials.

Pharmaceutical Contract Packaging Market, By Application

• Prescription Drugs
• Over-the-counter (OTC) Drugs
• Nutraceuticals and Dietary Supplements
• Clinical Trials

Based on the application, the Pharmaceutical Contract Packaging Market is segmented into Prescription Drugs and other segments. The Prescription Drugs segment holds a significant market share. Prescription drugs represent a major portion of the pharmaceutical industry’s product portfolio, leading to a high demand for contract packaging services tailored to these products.

Pharmaceutical Contract Packaging Market, By Geography

• North America
• Europe
• Asia-Pacific
• Middle East and Africa
• Latin America

Based on geography

the Pharmaceutical Contract Packaging Market is segmented into North America and other regions. The North American segment holds a prominent market share, driven by the following factorsNorth America is considered a dominant region in the pharmaceutical contract packaging market, owing to the presence of a well-established pharmaceutical industry and a large number of contract packaging organizations.

Key Players

The “Pharmaceutical Contract Packaging Market” study report will provide valuable insight with an emphasis on the global market including some of the major players such as Catalent, Inc., Patheon (Thermo Fisher Scientific Inc.), Baxter BioPharma Solutions, Amcor plc, BALL CORPORATION, Nipro Corporation, Daito Pharmaceutical Co., Ltd., Pfizer CentreOne, West Pharmaceutical Services, Inc., WestRock Company, Catalent, Inc., Patheon (Thermo Fisher Scientific Inc.), Baxter BioPharma Solutions, Amcor plc, BALL CORPORATION, Nipro Corporation, Daito Pharmaceutical Co., Ltd., Pfizer CentreOne, West Pharmaceutical Services, Inc., WestRock Company

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Pharmaceutical Contract Packaging Market Key Developments

• In May 2021 – Sharp, a contract packaging, clinical supply services company owned by UDG Healthcare plc, purchased new land as part of a USD 17 million investment in its Conshohocken, PA location. This land purchase will enable Sharp to add future capacity for cGMP packaging services and is part of a broader USD 43 million investment into its Pennsylvania operations, increasing the firm’s blister packaging capacity by over 35%.
• In June 2020 – PCI Pharma announced that it entered into a partnership agreement with Experic, a contract manufacturing organization, and pharmaceutical supply service company, to explore clinical and commercial manufacturing, packaging, and supply chain services driving collective growth for both parties.

Report Scope

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post-sales analyst support

Customization of the Report

• In case of any please connect with our sales team, who will ensure that your requirements are met.